Antacid therapy in IPF: The Lancet Respiratory Medicine: June 23, 2017
The Lancet Respiratory Medicine in conversation with - Un pódcast de The Lancet Group
Categorías:
Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
